author-photo

Christina R. Lee

Memorial Sloan Kettering Cancer Center

2

Papers

8

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)
Impact of circulating endothelial progenitor cells on the growth of viable tumor rim after treatment with a vascular disrupting agent.

2006 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)